Autoimmunity, The Thyroid, Low-dose Naltrexone (LDN) & Beyond (LDN) from LDN Research Trust on Vimeo.

Dr. Yousuf Siddiqui, B.Arch.Sci., N.D

Autoimmunity, The Thyroid, Low-dose Naltrexone (LDN) & Beyond

Alteration of prescription-only drug utilization by low dose naltrexone users with hypothyroidism. A cohort study based on the Norwegian prescription database from 2011-2015

Research in Social and Administrative Pharmacy
May–June 2017
https://www.sciencedirect.com/science/article/abs/pii/S1551741117302152

No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study (Abstract)

BMC Endocr Disord
01 Oct 2020
https://pubmed.ncbi.nlm.nih.gov/33004044/

 

John Robinson, NMD - Thyroid Disease: Optimizing Metabolism Through Comprehensive Hormonal Treatment (2017 Conference) (LDN, low dose naltrexone)

Dr John Robinson begins this 80 minute presentation with a diagram showing the links between growth hormones, sex hormones and the thyroid gland. In turn, the diagram also demonstrates how these can have effects on sexuality, musculoskeletal function and immunity.

 

Sarah Zielsdorf, MD, MS - Patient on Fire: Hashimoto's (2017 Conference) (LDN, low dose naltrexone)

Dr Zielsdorf is a functional medicine physician and a board certified internist at the Institute for personal development. Sarah practices in Romeoville and Morris, Illinois in the United States.

 

Dr Kent Holtorf delivers his presentation on Thyroid Conditions at the LDN 2014 Conference.

In this presentation Dr Holtorf speaks about the mechanisms which Hashimoto’s and Grave’s disease operate under and how, after many years of research and practice, they can be countered through unconventional treatments.